{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,19]],"date-time":"2026-10-19T23:38:33Z","timestamp":1792453113467,"version":"4.5.0"},"reference-count":69,"publisher":"Elsevier BV","issue":"4","license":[{"start":{"date-parts":[[2026,4,1]],"date-time":"2026-04-01T00:00:00Z","timestamp":1775001600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,4,1]],"date-time":"2026-04-01T00:00:00Z","timestamp":1775001600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"funder":[{"DOI":"10.13039\/100018078","name":"American Center for Reproductive Medicine, Cleveland Clinic","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100018078","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["archives-pmr.org","clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Archives of Physical Medicine and Rehabilitation"],"published-print":{"date-parts":[[2026,4]]},"DOI":"10.1016\/j.apmr.2025.09.038","type":"journal-article","created":{"date-parts":[[2025,11,21]],"date-time":"2025-11-21T22:49:58Z","timestamp":1763765398000},"page":"761-777","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":2,"title":["Systematic Review on Norepinephrine and Dopamine Reuptake Inhibitors for Traumatic Brain Injury-Related Symptoms: Report of the American Congress of Rehabilitation Medicine"],"prefix":"10.1016","volume":"107","author":[{"ORCID":"https:\/\/orcid.org\/0009-0007-9899-876X","authenticated-orcid":false,"given":"Ronald T.","family":"Seel","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"David B.","family":"Arciniegas","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Stephen P.","family":"Macciocchi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"David X.","family":"Cifu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yelena Goldin","family":"Frazier","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Darryl L.","family":"Kaelin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Douglas I.","family":"Katz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tolu O.","family":"Oyesanya","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Masoud","family":"Pourrahmat","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Thomas","family":"Schofield","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Amy K.","family":"Wagner","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mir Sohail","family":"Fazeli","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.apmr.2025.09.038_bib0001","series-title":"Textbook of traumatic brain injury","first-page":"247","article-title":"Neurocognitive disorders","author":"Arciniegas","year":"2019"},{"key":"10.1016\/j.apmr.2025.09.038_bib0002","doi-asserted-by":"crossref","first-page":"64","DOI":"10.1055\/s-0035-1544241","article-title":"Neuropsychiatric disturbances associated with traumatic brain injury: a practical approach to evaluation and management","volume":"35","author":"Rao","year":"2015","journal-title":"Semin Neurol"},{"key":"10.1016\/j.apmr.2025.09.038_bib0003","series-title":"Braddom\u2019s physical medicine and rehabilitation","first-page":"916","article-title":"Chapter 43 Traumatic brain injury","author":"Wagner","year":"2020"},{"key":"10.1016\/j.apmr.2025.09.038_bib0004","doi-asserted-by":"crossref","first-page":"430","DOI":"10.1097\/HTR.0b013e3181c133e9","article-title":"Cognitive outcome following traumatic brain injury","volume":"24","author":"Dikmen","year":"2009","journal-title":"J Head Trauma Rehabil"},{"key":"10.1016\/j.apmr.2025.09.038_bib0005","series-title":"Textbook of traumatic brain injury","author":"Silver","year":"2019"},{"key":"10.1016\/j.apmr.2025.09.038_bib0006","doi-asserted-by":"crossref","first-page":"1113","DOI":"10.1016\/S0003-9993(95)80118-9","article-title":"Explaining quality of life for persons with traumatic brain injuries 2 years after injury","volume":"76","author":"Webb","year":"1995","journal-title":"Arch Phys Med Rehabil"},{"key":"10.1016\/j.apmr.2025.09.038_bib0007","series-title":"Demos Medical","article-title":"Brain injury medicine: principles and practice","author":"Zasler","year":"2021"},{"key":"10.1016\/j.apmr.2025.09.038_bib0008","series-title":"Ontario Neurotrauma Foundation","article-title":"Guideline for concussion\/mild traumatic brain injury and prolonged symptoms (for adults 18+ years of age)","author":"Marshall","year":"2018"},{"key":"10.1016\/j.apmr.2025.09.038_bib0009","series-title":"VA\/DoD clinical practice guideline for the management and rehabilitation of post-acute mild traumatic brain injury, version 3.0","year":"2021"},{"key":"10.1016\/j.apmr.2025.09.038_bib0010","doi-asserted-by":"crossref","first-page":"1515","DOI":"10.1016\/j.apmr.2019.02.011","article-title":"Evidence-based cognitive rehabilitation: systematic review of the literature from 2009 through 2014","volume":"100","author":"Cicerone","year":"2019","journal-title":"Arch Phys Med Rehabil"},{"key":"10.1016\/j.apmr.2025.09.038_bib0011","series-title":"Behavioral neurology neuropsychiatry","first-page":"511","article-title":"Rehabilitation and pharmacotherapy of cognitive impairments","author":"Arciniegas","year":"2013"},{"key":"10.1016\/j.apmr.2025.09.038_bib0012","series-title":"Behavioral neurology neuropsychiatry","first-page":"566","article-title":"Pharmacotherapy of behavioral disturbances","author":"McAllister","year":"2013"},{"key":"10.1016\/j.apmr.2025.09.038_bib0013","doi-asserted-by":"crossref","first-page":"1468","DOI":"10.1089\/neu.2006.23.1468","article-title":"Guidelines for the pharmacologic treatment of neurobehavioral sequelae of traumatic brain injury","volume":"23","author":"Warden","year":"2006","journal-title":"J Neurotrauma"},{"key":"10.1016\/j.apmr.2025.09.038_bib0014","doi-asserted-by":"crossref","first-page":"291","DOI":"10.3390\/brainsci9110291","article-title":"Effects of methylphenidate on cognitive function in adults with traumatic brain injury: a meta-analysis","volume":"9","author":"Chien","year":"2019","journal-title":"Brain Sci"},{"key":"10.1016\/j.apmr.2025.09.038_bib0015","doi-asserted-by":"crossref","first-page":"2886","DOI":"10.1089\/neu.2018.6290","article-title":"Practice patterns in pharmacological and non-pharmacological therapies for children with mild traumatic brain injury: a survey of 15 Canadian and United States Centers","volume":"36","author":"Mannix","year":"2019","journal-title":"J Neurotrauma"},{"key":"10.1016\/j.apmr.2025.09.038_bib0016","doi-asserted-by":"crossref","first-page":"1254","DOI":"10.1177\/1060028020983607","article-title":"A review of pharmacologic neurostimulant use during rehabilitation and recovery after brain injury","volume":"55","author":"Kakehi","year":"2021","journal-title":"Ann Pharmacother"},{"key":"10.1016\/j.apmr.2025.09.038_bib0017","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1155\/2006\/460592","article-title":"Pharmacotherapy of posttraumatic cognitive impairments","volume":"17","author":"Arciniegas","year":"2006","journal-title":"Behav Neurol"},{"key":"10.1016\/j.apmr.2025.09.038_bib0018","doi-asserted-by":"crossref","first-page":"702","DOI":"10.1002\/jnr.24102","article-title":"Effects of dextroamphetamine in subacute traumatic brain injury: a randomized, placebo-controlled pilot study","volume":"96","author":"Hart","year":"2018","journal-title":"J Neurosci Res"},{"key":"10.1016\/j.apmr.2025.09.038_bib0019","doi-asserted-by":"crossref","first-page":"1461","DOI":"10.3109\/02699052.2014.930179","article-title":"Traumatic brain injury-related attention deficits: treatment outcomes with lisdexamfetamine dimesylate (Vyvanse)","volume":"28","author":"Tramontana","year":"2014","journal-title":"Brain Inj"},{"key":"10.1016\/j.apmr.2025.09.038_bib0020","unstructured":"Gronseth GS, Cox J, Gloss D, et al. on behalf of the Guideline Development, Dissemination, and Implementation Subcommittee of the American Academy of Neurology. Clinical Practice Guideline Process Manual, 2017 ed., The American Academy of Neurology: Minneapolis, MN."},{"key":"10.1016\/j.apmr.2025.09.038_bib0021","unstructured":"American Congress of Rehabilitation Medicine (ACRM) Evidence and Practice Committee. Guideline development. Available at: https:\/\/acrm.org\/about\/committees-groups\/evidence-and-practice\/. Accessed August 9, 2024."},{"key":"10.1016\/j.apmr.2025.09.038_bib0022","article-title":"The PRISMA 2020 statement: an updated guideline for reporting systematic reviews","volume":"18","author":"Page","year":"2020","journal-title":"PLoS Med"},{"key":"10.1016\/j.apmr.2025.09.038_bib0023","doi-asserted-by":"crossref","first-page":"131","DOI":"10.1097\/01.phm.0000112308.68586.1d","article-title":"Effect of methylphenidate on vital signs and adverse effects in adults with traumatic brain injury","volume":"83","author":"Alban","year":"2004","journal-title":"Am J Phys Med Rehabil"},{"key":"10.1016\/j.apmr.2025.09.038_bib0024","doi-asserted-by":"crossref","first-page":"758","DOI":"10.3109\/02699052.2015.1004747","article-title":"Methylphenidate reduces mental fatigue and improves processing speed in persons suffered a traumatic brain injury","volume":"29","author":"Johansson","year":"2015","journal-title":"Brain Inj"},{"key":"10.1016\/j.apmr.2025.09.038_bib0025","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1007\/s00213-011-2622-8","article-title":"Methylphenidate modulates sustained attention and cortical activation in survivors of traumatic brain injury: a perfusion fMRI study","volume":"222","author":"Kim","year":"2012","journal-title":"Psychopharmacology (Berl)"},{"key":"10.1016\/j.apmr.2025.09.038_bib0026","doi-asserted-by":"crossref","first-page":"24","DOI":"10.1191\/0269215506cr927oa","article-title":"Effects of single-dose methylphenidate on cognitive performance in patients with traumatic brain injury: a double-blind placebo-controlled study","volume":"20","author":"Kim","year":"2006","journal-title":"Clin Rehabil"},{"key":"10.1016\/j.apmr.2025.09.038_bib0027","doi-asserted-by":"crossref","first-page":"97","DOI":"10.1002\/hup.668","article-title":"Comparing effects of methylphenidate, sertraline and placebo on neuropsychiatric sequelae in patients with traumatic brain injury","volume":"20","author":"Lee","year":"2005","journal-title":"Hum Psychopharmacol"},{"key":"10.1016\/j.apmr.2025.09.038_bib0028","doi-asserted-by":"crossref","first-page":"1191","DOI":"10.1038\/npp.2015.282","article-title":"Randomized placebo-controlled trial of methylphenidate or galantamine for persistent emotional and cognitive symptoms associated with PTSD and\/or traumatic brain injury","volume":"41","author":"McAllister","year":"2016","journal-title":"Neuropsychopharmacology"},{"key":"10.1016\/j.apmr.2025.09.038_bib0029","doi-asserted-by":"crossref","first-page":"1766","DOI":"10.1038\/npp.2016.261","article-title":"Methylphenidate and memory and attention adaptation training for persistent cognitive symptoms after traumatic brain injury: a randomized, placebo-controlled trial","volume":"42","author":"McDonald","year":"2017","journal-title":"Neuropsychopharmacology"},{"key":"10.1016\/j.apmr.2025.09.038_bib0030","first-page":"153","article-title":"Effect of methylphenidate on brain injury-related anger","volume":"74","author":"Mooney","year":"1993","journal-title":"Arch Phys Med Rehabil"},{"key":"10.1016\/j.apmr.2025.09.038_bib0031","doi-asserted-by":"crossref","first-page":"333","DOI":"10.3109\/02699059309034959","article-title":"A double-blind controlled study of methylphenidate treatment in closed head injury","volume":"7","author":"Speech","year":"1993","journal-title":"Brain Inj"},{"key":"10.1016\/j.apmr.2025.09.038_bib0032","doi-asserted-by":"crossref","first-page":"440","DOI":"10.1097\/00002060-199711000-00002","article-title":"Effects of methylphenidate on attentional function after traumatic brain injury. A randomized, placebo-controlled trial","volume":"76","author":"Whyte","year":"1997","journal-title":"Am J Phys Med Rehabil"},{"key":"10.1016\/j.apmr.2025.09.038_bib0033","doi-asserted-by":"crossref","first-page":"401","DOI":"10.1097\/01.PHM.0000128789.75375.D3","article-title":"Effects of methylphenidate on attention deficits after traumatic brain injury: a multidimensional, randomized, controlled trial","volume":"83","author":"Whyte","year":"2004","journal-title":"Am J Phys Med Rehabil"},{"key":"10.1016\/j.apmr.2025.09.038_bib0034","doi-asserted-by":"crossref","first-page":"552","DOI":"10.1136\/jnnp.2008.159632","article-title":"Efficacy of methylphenidate in the rehabilitation of attention following traumatic brain injury: a randomised, crossover, double blind, placebo controlled inpatient trial","volume":"80","author":"Willmott","year":"2009","journal-title":"J Neurol Neurosurg Psychiatry"},{"key":"10.1016\/j.apmr.2025.09.038_bib0035","doi-asserted-by":"crossref","first-page":"585","DOI":"10.2340\/16501977-0369","article-title":"Safety of methylphenidate following traumatic brain injury: impact on vital signs and side-effects during inpatient rehabilitation","volume":"41","author":"Willmott","year":"2009","journal-title":"J Rehabil Med"},{"key":"10.1016\/j.apmr.2025.09.038_bib0036","first-page":"86","article-title":"Methylphenidate and seizure frequency in brain injured patients with seizure disorders","volume":"53","author":"Wroblewski","year":"1992","journal-title":"J Clin Psychiatry"},{"key":"10.1016\/j.apmr.2025.09.038_bib0037","doi-asserted-by":"crossref","first-page":"e6960","DOI":"10.1097\/MD.0000000000006960","article-title":"Efficacy of methylphenidate for the treatment of mental sequelae after traumatic brain injury","volume":"96","author":"Zhang","year":"2017","journal-title":"Medicine (Baltimore)"},{"key":"10.1016\/j.apmr.2025.09.038_bib0038","series-title":"Neuropsychological assessment","author":"Lezak","year":"2012"},{"key":"10.1016\/j.apmr.2025.09.038_bib0039","series-title":"A compendium of neuropsychological tests: administration, norms, and commentary","author":"Strauss","year":"2006"},{"key":"10.1016\/j.apmr.2025.09.038_bib0040","doi-asserted-by":"crossref","first-page":"105","DOI":"10.1016\/j.cct.2006.04.004","article-title":"Random-effects model for meta-analysis of clinical trials: an update","volume":"28","author":"DerSimonian","year":"2007","journal-title":"Contemp Clin Trials"},{"key":"10.1016\/j.apmr.2025.09.038_bib0041","doi-asserted-by":"crossref","first-page":"177","DOI":"10.1016\/0197-2456(86)90046-2","article-title":"Meta-analysis in clinical trials","volume":"7","author":"DerSimonian","year":"1986","journal-title":"Control Clin Trials"},{"key":"10.1016\/j.apmr.2025.09.038_bib0042","doi-asserted-by":"crossref","first-page":"825","DOI":"10.1002\/sim.650","article-title":"A comparison of statistical methods for meta-analysis","volume":"20","author":"Brockwell","year":"2001","journal-title":"Stat Med"},{"key":"10.1016\/j.apmr.2025.09.038_bib0043","doi-asserted-by":"crossref","first-page":"619","DOI":"10.1002\/(SICI)1097-0258(19960330)15:6<619::AID-SIM188>3.0.CO;2-A","article-title":"A likelihood approach to meta-analysis with random effects","volume":"15","author":"Hardy","year":"1996","journal-title":"Stat Med"},{"key":"10.1016\/j.apmr.2025.09.038_bib69","doi-asserted-by":"crossref","DOI":"10.1016\/j.apmr.2025.08.024","article-title":"Practice guideline for methylphenidate use in persons with traumatic brain injury: Report of the american congress of rehabilitation medicine","author":"Arciniegas","year":"2026","journal-title":"Arch Phys Med Rehabil"},{"key":"10.1016\/j.apmr.2025.09.038_bib0044","doi-asserted-by":"crossref","first-page":"1179","DOI":"10.1093\/cercor\/bhs107","article-title":"Methylphenidate effects on neural activity during response inhibition in healthy humans","volume":"23","author":"Costa","year":"2013","journal-title":"Cereb Cortex"},{"key":"10.1016\/j.apmr.2025.09.038_bib0045","doi-asserted-by":"crossref","first-page":"661","DOI":"10.1007\/s40264-014-0201-8","article-title":"Cardiovascular effects of methylphenidate, amphetamines and atomoxetine in the treatment of attention-deficit hyperactivity disorder: an update","volume":"37","author":"Awudu","year":"2014","journal-title":"Drug Saf"},{"key":"10.1016\/j.apmr.2025.09.038_bib0046","doi-asserted-by":"crossref","first-page":"199","DOI":"10.1007\/s40263-017-0410-7","article-title":"Cardiovascular effects of stimulant and non-stimulant medication for children and adolescents with ADHD: a systematic review and meta-analysis of trials of methylphenidate, amphetamines and atomoxetine","volume":"31","author":"Hennissen","year":"2017","journal-title":"CNS Drugs"},{"key":"10.1016\/j.apmr.2025.09.038_bib0047","doi-asserted-by":"crossref","first-page":"821","DOI":"10.2165\/11536380-000000000-00000","article-title":"Cardiovascular effects of methylphenidate, amphetamines and atomoxetine in the treatment of attention-deficit hyperactivity disorder","volume":"33","author":"Stiefel","year":"2010","journal-title":"Drug Saf"},{"key":"10.1016\/j.apmr.2025.09.038_bib0048","doi-asserted-by":"crossref","first-page":"925","DOI":"10.3389\/fneur.2019.00925","article-title":"Methylphenidate treatment of cognitive dysfunction in adults after mild to moderate traumatic brain injury: rationale, efficacy, and neural mechanisms","volume":"10","author":"Levin","year":"2019","journal-title":"Front Neurol"},{"key":"10.1016\/j.apmr.2025.09.038_bib0049","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1016\/j.brainres.2015.12.026","article-title":"Catecholaminergic based therapies for functional recovery after TBI","volume":"1640","author":"Osier","year":"2016","journal-title":"Brain Res"},{"key":"10.1016\/j.apmr.2025.09.038_bib0050","doi-asserted-by":"crossref","first-page":"981","DOI":"10.1016\/j.neubiorev.2009.03.011","article-title":"Persistent cognitive dysfunction after traumatic brain injury: a dopamine hypothesis","volume":"33","author":"Bales","year":"2009","journal-title":"Neurosci Biobehav Rev"},{"key":"10.1016\/j.apmr.2025.09.038_bib0051","doi-asserted-by":"crossref","first-page":"405","DOI":"10.1016\/j.neuropharm.2006.07.035","article-title":"Effects of amphetamine isomers, methylphenidate and atomoxetine on synaptosomal and synaptic vesicle accumulation and release of dopamine and noradrenaline in vitro in the rat brain","volume":"52","author":"Easton","year":"2007","journal-title":"Neuropharmacology"},{"key":"10.1016\/j.apmr.2025.09.038_bib0052","doi-asserted-by":"crossref","first-page":"2032","DOI":"10.1046\/j.1471-4159.1997.68052032.x","article-title":"Effects of methylphenidate on extracellular dopamine, serotonin, and norepinephrine: comparison with amphetamine","volume":"68","author":"Kuczenski","year":"1997","journal-title":"J Neurochem"},{"key":"10.1016\/j.apmr.2025.09.038_bib0053","doi-asserted-by":"crossref","first-page":"213","DOI":"10.1016\/j.brainres.2010.09.109","article-title":"Amphetamine alters behavior and mesocorticolimbic dopamine receptor expression in the monogamous female prairie vole","volume":"1367","author":"Young","year":"2011","journal-title":"Brain Res"},{"key":"10.1016\/j.apmr.2025.09.038_bib0054","doi-asserted-by":"crossref","first-page":"457","DOI":"10.1111\/j.1471-4159.2005.03382.x","article-title":"Controlled cortical impact injury affects dopaminergic transmission in the rat striatum","volume":"95","author":"Wagner","year":"2005","journal-title":"J Neurochem"},{"key":"10.1016\/j.apmr.2025.09.038_bib0055","doi-asserted-by":"crossref","first-page":"986","DOI":"10.1111\/j.1471-4159.2008.05840.x","article-title":"Chronic methylphenidate treatment enhances striatal dopamine neurotransmission after experimental traumatic brain injury","volume":"108","author":"Wagner","year":"2009","journal-title":"J Neurochem"},{"key":"10.1016\/j.apmr.2025.09.038_bib0056","doi-asserted-by":"crossref","first-page":"475","DOI":"10.1016\/j.expneurol.2005.06.009","article-title":"Gender and environmental enrichment impact dopamine transporter expression after experimental traumatic brain injury","volume":"195","author":"Wagner","year":"2005","journal-title":"Exp Neurol"},{"key":"10.1016\/j.apmr.2025.09.038_bib0057","doi-asserted-by":"crossref","first-page":"85","DOI":"10.1002\/jnr.20419","article-title":"Synaptosomal dopamine uptake in rat striatum following controlled cortical impact","volume":"80","author":"Wilson","year":"2005","journal-title":"J Neurosci Res"},{"key":"10.1016\/j.apmr.2025.09.038_bib0058","doi-asserted-by":"crossref","first-page":"1899","DOI":"10.1097\/00001756-200210280-00013","article-title":"Traumatic brain injury reduces dopamine transporter protein expression in the rat frontal cortex","volume":"13","author":"Yan","year":"2002","journal-title":"Neuroreport"},{"key":"10.1016\/j.apmr.2025.09.038_bib0059","doi-asserted-by":"crossref","first-page":"801","DOI":"10.1111\/j.1471-4159.2009.06155.x","article-title":"Controlled cortical impact injury influences methylphenidate-induced changes in striatal dopamine neurotransmission","volume":"110","author":"Wagner","year":"2009","journal-title":"J Neurochem"},{"key":"10.1016\/j.apmr.2025.09.038_bib0060","doi-asserted-by":"crossref","DOI":"10.1016\/j.nicl.2019.101950","article-title":"Dopamine D2\/D3 receptor abnormalities after traumatic brain injury and their relationship to post-traumatic depression","volume":"24","author":"Jolly","year":"2019","journal-title":"Neuroimage Clin"},{"key":"10.1016\/j.apmr.2025.09.038_bib0061","doi-asserted-by":"crossref","first-page":"1410","DOI":"10.1007\/s002590000308","article-title":"Impaired dopaminergic neurotransmission in patients with traumatic brain injury: a SPECT study using 123I-beta-CIT and 123I-IBZM","volume":"27","author":"Donnemiller","year":"2000","journal-title":"Eur J Nucl Med"},{"key":"10.1016\/j.apmr.2025.09.038_bib0062","doi-asserted-by":"crossref","first-page":"1328","DOI":"10.1038\/jcbfm.2014.87","article-title":"The influence of genetic variants on striatal dopamine transporter and D2 receptor binding after TBI","volume":"34","author":"Wagner","year":"2014","journal-title":"J Cereb Blood Flow Metab"},{"key":"10.1016\/j.apmr.2025.09.038_bib0063","doi-asserted-by":"crossref","first-page":"785","DOI":"10.1016\/S0149-7634(02)00065-9","article-title":"Functional imaging studies of dopamine system and cognition in normal aging and Parkinson\u2019s disease","volume":"26","author":"Kaasinen","year":"2002","journal-title":"Neurosci Biobehav Rev"},{"key":"10.1016\/j.apmr.2025.09.038_bib0064","doi-asserted-by":"crossref","first-page":"359","DOI":"10.1002\/gps.606","article-title":"Ageing and the nigrostriatal dopaminergic system","volume":"17","author":"Reeves","year":"2002","journal-title":"Int J Geriatr Psychiatry"},{"key":"10.1016\/j.apmr.2025.09.038_bib0065","doi-asserted-by":"crossref","first-page":"E15","DOI":"10.1097\/HTR.0000000000000199","article-title":"A dopamine pathway gene risk score for cognitive recovery following traumatic brain injury: methodological considerations, preliminary findings, and interactions with sex","volume":"31","author":"Myrga","year":"2016","journal-title":"J Head Trauma Rehabil"},{"key":"10.1016\/j.apmr.2025.09.038_bib0066","doi-asserted-by":"crossref","first-page":"200","DOI":"10.1016\/j.bbr.2007.04.006","article-title":"Gender associations with chronic methylphenidate treatment and behavioral performance following experimental traumatic brain injury","volume":"181","author":"Wagner","year":"2007","journal-title":"Behav Brain Res"},{"key":"10.1016\/j.apmr.2025.09.038_bib0067","doi-asserted-by":"crossref","first-page":"733","DOI":"10.1177\/0269215516655590","article-title":"The efficacy and safety of extended-release methylphenidate following traumatic brain injury: a randomised controlled pilot study","volume":"31","author":"Dymowski","year":"2017","journal-title":"Clin Rehabil"},{"key":"10.1016\/j.apmr.2025.09.038_bib0068","unstructured":"Prescriber\u2019s Digital Reference. Concerta\/methylphenidate hydrochloride \u2013 drug summary. Available at: https:\/\/www.pdr.net\/drug-summary\/?drugLabelId=24298. Accessed August 9, 2024."}],"container-title":["Archives of Physical Medicine and Rehabilitation"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0003999325010561?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0003999325010561?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,6,23]],"date-time":"2026-06-23T04:08:57Z","timestamp":1782187737000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0003999325010561"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,4]]},"references-count":69,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2026,4]]}},"alternative-id":["S0003999325010561"],"URL":"https:\/\/doi.org\/10.1016\/j.apmr.2025.09.038","relation":{},"ISSN":["0003-9993"],"issn-type":[{"value":"0003-9993","type":"print"}],"subject":[],"published":{"date-parts":[[2026,4]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Systematic Review on Norepinephrine and Dopamine Reuptake Inhibitors for Traumatic Brain Injury-Related Symptoms: Report of the American Congress of Rehabilitation Medicine","name":"articletitle","label":"Article Title"},{"value":"Archives of Physical Medicine and Rehabilitation","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.apmr.2025.09.038","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 by the American Congress of Rehabilitation Medicine","name":"copyright","label":"Copyright"}]}}